Catena Biosciences

Catena Biosciences is a biotechnology company specializing in the development of novel therapeutic structures through its proprietary CysTyr™ Conjugation Platform. This platform is designed to revolutionize antibody-drug conjugates (ADCs) by enabling the creation of Multi-Payload Conjugates (MPCs) that can deliver dual payloads effectively. The company focuses primarily on addressing high unmet medical needs in solid tumors, aiming to improve treatment outcomes compared to current standards of care.

The CysTyr platform overcomes significant limitations of traditional ADCs, which are often res…